Nora Volkow is the Director of NIDA. In her commentary she describes a range of important advances in the field of addiction medicine.
She points to early research on GLP-1 medications, psychedelic compounds and neuromodulation as signs that new addiction treatment options are on the horizon. But proven medications for opioid use disorder remain underused.
Accessing the Best Treatments
Meds have been shown to be one of the most effective treatments for opioid use disorder when they’re combined with counseling. Drugs like methadone and buprenorphine help people stop using opioids and improve their overall quality of life.
Unfortunately a lot of people who could be helped by these meds have trouble getting them. This is especially the case in rural areas where finding a provider willing to prescribe them, or even a pharmacy that stocks them, can be a challenge.
GLP-1 Drugs Draw Research Attention
One of the most closely watched research areas involves glucagon-like peptide-1 receptor agonists. This is the drug class that includes semaglutides such as Ozempic and Wegovy.
There’s also a related class of drugs called tirzepatide or Zepbound. These medications are known for managing weight loss and diabetes and early research suggests they may also help treat addiction.
Psychedelics and Neuromodulation
There’s also a lot of important research into psychedelics and psychedelic based medicines for addiction. These compounds remain mostly experimental but early studies suggest they may help rewire brain circuits disrupted by addiction.
Another promising avenue is neuromodulation. This approach uses tools like focused ultrasound or electrical or magnetic pulses to alter activity in the reward circuits that drug use disrupts.
Where Addiction Treatment Science Is Heading
NIDA’s research push aligns with the goals of the Great American Recovery initiative. The focus there is on expanding access to proven medications while investing in innovative therapies.
What This Means for Treatment Seekers
Medications for opioid use disorder, evidence-based behavioral therapies, and structured programs all have strong track records and the larger barrier is access rather than effectiveness.
At the same time, the research pipeline suggests the treatment options available in five years may look different from today’s.
People in rural areas who struggle to find prescribers may need to search more broadly, asking treatment providers directly about medication availability when comparing programs.
For providers, Volkow’s commentary describes a field with a two-front problem. There are proven tools that reach too few patients and experimental tools that still need years of validation before they can be prescribed.
Exploring Treatment Options
If you or someone you love is researching addiction treatment then practical next steps include comparing rehab centers and their credentials, understanding how insurance coverage for rehab works and asking each facility about the different therapies and medications available.
If opioid use disorder is part of the picture then ask whether the facility provides medication-assisted treatment or can refer you to a prescriber.
Rehab.com’s directory can help you compare treatment centers and approaches. Call
800-985-8516
( 
Sponsored Helpline )
to speak with someone about treatment options.
